Protagonist Therapeutics, Inc PTGX
- PN-477 — Obesity Phase 1
- PN-477 — Obesity Phase 1
- PN-477 Phase 1
- PN-458 Preclinical
GIP (3 companies · 6 programs)
Companies with an active program directed at GIP.
FRACTYL HEALTH, INC. GUTS
- Rejuva — Obesity Preclinical
Viking Therapeutics, Inc. VKTX
- VK2735 — Obesity Phase 3